TNF and metabolic dysfunction-associated steatohepatitis: In addition, TNF‐α was supposed to be a pivotal mediator of NASH development,86 and inhibition of TNF‐α activity by anti‐inflammatory drugs ameliorated inflammation, liver damage and NASH.87